Please login to the form below

Not currently logged in
Email:
Password:

Co-operative Pharmacy rebrands as Well

Work carried out by advertising agency Langland
Well pharmacy logo

The UK's Co-operative Pharmacy has rebranded under the new name of Well

The new title is designed to reflect changing attitudes towards health, as the firm believe the public are now taking a more active role in personal wellness, and also connects with the idea of a well being a central feature of a healthy community. 

Work on the rebrand was lead by healthcare advertising agency Langland. The company's managing partner Kate Spencer commented: “This rebrand reflects modern attitudes to health, as the conversation has shifted from illness to wellness. 

“The new brand, with significant investment from Bestway, will be the first to deliver the kind of accessible, local healthcare people want and need, to complement the service they get from their GP.”

It is hoped that the rebrand will improve levels of public trust for the pharmacy, which is also hoping to expand its role within the community by adding services and more personalised care.

This is in line with wider UK plans to increase its influence on the public's health and offer primary care services outside the GP's office.

Bestway acquired the chain as part of a £620m deal. The Well brand is expected to be a platform for significant growth, with £200m of investment planned. It is hoped that the rebranding will increase revenues from £750m to £1bn by 2019.

Co-operative Pharmacy is the UK's third-largest pharmacy chain with 780 stores and more than 7,000 employees.

Article by
Kirstie Pickering

12th February 2015

From: Marketing, Healthcare

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

#DemandDiversity: New research on COVID-19 clinical trial perceptions within minorities and high-risk populations
Lack of diversity in clinical trials still remains on of the biggest issues for COVID-19 clinical trials. But despite the growing discussions, calls for change, growing regulatory guidance and much...
Pandemic preparedness
The pandemic preparedness paradox
Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...
Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...

Infographics